|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | G01N 33/50 | (2006.01) |
| G01N 33/68 | (2006.01) | ||
| G01N 33/53 | (2006.01) |
| (11) | Number of the document | 3792628 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20193183.9 |
| Date of filing the European patent application | 2017-05-10 | |
| (97) | Date of publication of the European application | 2021-03-17 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-24 |
| (46) | Date of publication of the claims translation | 2024-06-25 |
| (30) | Number | Date | Country code |
| PCT/EP2016/060897 | 2016-05-13 | WO |
| (72) |
VORMEHR, Mathias , DE
SAHIN, Ugur , DE
SCHRÖRS, Barbara , DE
LÖWER, Martin , DE
BOEGEL, Sebastian , DE
|
| (73) |
BioNTech SE ,
An der Goldgrube 12, 55131 Mainz,
DE
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neoantigenų tinkamumo imunoterapijai prognozavimo metodai |
| METHODS FOR PREDICTING THE USEFULNESS OF NEOANTIGENS FOR IMMUNOTHERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 9 | 208.00 EUR |
| 2026-05-10 |